Important Notes, Directory, and Definitions
The Board of Directors and senior management of Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. guarantee that the content of the annual report is true, accurate, and complete, with no false records, misleading statements, or significant omissions, and bear individual and joint legal responsibilities. The responsible person Yu Feng, the head of accounting Ren Gaofeng, and the head of the accounting institution Wang Hongxia declare: they ensure the financial report in this annual report is true, accurate, and complete. All directors have attended the board meeting to review this report. The forward-looking statements regarding future plans in this report do not constitute a substantive commitment to investors, nor do they represent the company's profit forecast for 2026. The realization depends on various factors, including changes in market conditions, and there is significant uncertainty; investors are advised to pay attention to investment risks. The risks and countermeasures that the company may face in its management have been described in Section 3, "Management Discussion and Analysis," under "11. Outlook for the Company's Future Development." Investors are encouraged to pay attention and be aware of investment risks. The profit distribution plan approved by the board of directors is: based on the total share capital registered on the equity distribution registration date, a cash dividend of CNY 2 (including tax) will be distributed for every 10 shares to all shareholders, with no bonus shares (including tax), and a capital reserve will be used to increase the share capital by 0 shares for every 10 shares to all shareholders.
Directory
- Important Notes, Directory, and Definitions ........................................................................................................ 1
- Company Profile and Key Financial Indicators .................................................................................................... 6
- Management Discussion and Analysis ................................................................................................................ 9
- Corporate Governance, Environment, and Society .............................................................................................. 34
- Important Matters ............................................................................................................................................... 52
- Share Changes and Shareholder Information .................................................................................................... 89
- Bond-Related Information .................................................................................................................................. 98
- Financial Report .................................................................................................................................................. 99
Reference Documents Directory
- Original 2025 Annual Report signed by the company's legal representative.
- Financial statements signed and stamped by the responsible person, head of accounting, and head of the accounting institution.
- Original audit report stamped and signed by the accounting firm and certified public accountants.
- All original documents and announcements publicly disclosed on the designated website of the China Securities Regulatory Commission during the reporting period. The above reference documents are available at the company's address (9th Floor, No. 288 Yangshupu Road, Yangpu District, Shanghai) and the Shenzhen Stock Exchange (http://www.szse.cn/).